Assignee
QUANTERIX CORP
US·20 granted patents·18 pending applications·158 citations·filing 2008–2025
Top patents by PatentIndex Score
38 records- 0198US10725032B2Ultra-sensitive detection of molecules or particles using beads or other capture objectsQUANTERIX CORP·Filed 2017·Granted Jul 28, 2020·12 cites·18 claims
- 0298US9846155B2Methods and systems for extending dynamic range in assays for the detection of molecules or particlesQUANTERIX CORP·Filed 2015·Granted Dec 19, 2017·19 cites·19 claims
- 0397US12235267B2Ultra-sensitive detection of molecules or particles using beads or other capture objectsQUANTERIX CORP·Filed 2024·Granted Feb 25, 2025·2 cites·21 claims
- 0497US12019072B2Methods and systems for extending dynamic range in assays for the detection of molecules or particlesQUANTERIX CORP·Filed 2021·Granted Jun 25, 2024·3 cites·21 claims
- 0597US10989713B2Methods and systems for extending dynamic range in assays for the detection of molecules or particlesQUANTERIX CORP·Filed 2017·Granted Apr 27, 2021·10 cites·20 claims
- 0697US9551663B2Methods and systems for extending dynamic range in assays for the detection of molecules or particlesQUANTERIX CORP·Filed 2013·Granted Jan 24, 2017·29 cites·21 claims
- 0796US11619631B2Ultra-sensitive detection of molecules or particles using beads or other capture objectsQUANTERIX CORP·Filed 2019·Granted Apr 4, 2023·6 cites·20 claims
- 0894US11977087B2Systems, devices, and methods for ultra-sensitive detection of molecules or particlesQUANTERIX CORP·Filed 2021·Granted May 7, 2024·2 cites·17 claims
- 0994US11112415B2Systems, devices, and methods for ultra-sensitive detection of molecules or particlesQUANTERIX CORP·Filed 2018·Granted Sep 7, 2021·7 cites·30 claims
- 1093US11275092B2Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injuryQUANTERIX CORP·Filed 2019·Granted Mar 15, 2022·8 cites·21 claims
- 1193US10393759B2Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injuryQUANTERIX CORP·Filed 2016·Granted Aug 27, 2019·15 cites·25 claims
- 1293US2025180553A1Ultra-sensitive detection of molecules or particles using beads or other capture objectsQUANTERIX CORP·Filed 2024·Application pending·0 cites
- 1392US10640814B2Detection of DNA or RNA using single molecule arrays and other techniquesQUANTERIX CORP·Filed 2018·Granted May 5, 2020·12 cites·24 claims
- 1492US9932626B2Detection of DNA or RNA using single molecule arrays and other techniquesQUANTERIX CORP·Filed 2014·Granted Apr 3, 2018·17 cites·25 claims
- 1589US12130294B2Quantification of biomarkers present in physiological samplesQUANTERIX CORP·Filed 2019·Granted Oct 29, 2024·4 cites·16 claims
- 1689US12111324B2Quantification of biomarkers present in dried physiological samplesQUANTERIX CORP·Filed 2019·Granted Oct 8, 2024·4 cites·15 claims
- 1789US2024377397A1Methods and systems for extending dynamic range in assays for the detection of molecules or particlesQUANTERIX CORP·Filed 2024·Application pending·0 cites
- 1886US11434264B2Immunoassays for differential detection of clostridium difficileQUANTERIX CORP·Filed 2016·Granted Sep 6, 2022·7 cites·30 claims
- 1982US11686730B2Quantitative antibody testQUANTERIX CORP·Filed 2021·Granted Jun 27, 2023·1 cites·21 claims
- 2078US12540950B2Methods of assaying phosphorylated tau protein in a sampleQUANTERIX CORP·Filed 2025·Granted Feb 3, 2026·0 cites·42 claims
- 2178US2024201175A1Methods of determining a treatment protocol for and/or a prognosis of a patient’s recovery from a brain injury resulting from a hypoxic eventQUANTERIX CORP·Filed 2023·Application pending·0 cites
- 2277US12571803B2Methods of producing bodily fluid samples containing an analytically quantified amount of phosphorylated tau proteinQUANTERIX CORP·Filed 2022·Granted Mar 10, 2026·0 cites·22 claims
- 2377US2025341530A1Quantification of neurofilament light chain in physiological samplesQUANTERIX CORP·Filed 2025·Application pending·0 cites
- 2476US2022229074A1Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injuryQUANTERIX CORP·Filed 2022·Application pending·0 cites
- 2575US2020393457A1Ultra-sensitive detection of molecules or particles using beads or other capture objectsQUANTERIX CORP·Filed 2020·Application pending·0 cites
- 2671US2023213510A1Methods relating to improving accuracy of capture object-based assaysQUANTERIX CORP·Filed 2022·Application pending·0 cites
- 2768US12287343B2Quantification of neurofilament light chain in physiological samplesQUANTERIX CORP·Filed 2019·Granted Apr 29, 2025·0 cites·19 claims
- 2858US2023109130A1Methods and systems related to highly sensitive assays and delivering capture objectsQUANTERIX CORP·Filed 2022·Application pending·0 cites
- 2954US2022205992A1Materials and kits relating to association of reporter species and targeting entities with beadsQUANTERIX CORP·Filed 2020·Application pending·0 cites
- 3054US2017234882A9Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomyQUANTERIX CORP·Filed 2015·Application pending·0 cites
- 3151US2018003703A1Methods relating to improving accuracy of capture object-based assaysQUANTERIX CORP·Filed 2016·Application pending·0 cites
- 3251US2022050106A1Methods and kits for detecting sars-coronavirus-2 antigenQUANTERIX CORP·Filed 2021·Application pending·0 cites
- 3350US2010075862A1High sensitivity determination of the concentration of analyte molecules or particles in a fluid sampleQUANTERIX CORP·Filed 2008·Application pending·0 cites
- 3450US2016123969A1Methods, materials, and kits for covalently associating molecular species with a surface of an objectQUANTERIX CORP·Filed 2014·Application pending·0 cites
- 3549US2010075355A1Ultra-sensitive detection of enzymes by capture-and-release followed by quantificationQUANTERIX CORP·Filed 2008·Application pending·0 cites
- 3648US2010075439A1Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantificationQUANTERIX CORP·Filed 2008·Application pending·0 cites
- 3746US2020271643A1Methods and systems for the detection of analyte moleculesQUANTERIX CORP·Filed 2018·Application pending·0 cites
- 3840US2020123592A1Single molecule detection and quantification of nucleic acids with single base specificityQUANTERIX CORP·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →